NEW HAVEN, Conn., March 21 /PRNewswire-FirstCall/ -- Achillion
Pharmaceuticals, Inc. (Nasdaq: ACHN) expects to release its results for the
fourth quarter and year ended December 31, 2006 after the market closes on
Tuesday, March 27, 2007.
The company will host a conference call to discuss the results at 4:30
PM ET on March 27. The call may be joined via telephone by dialing (877)
502-9272 or (913) 981-5581 (for international participants) at least 5
minutes prior to the start of the call. An audio replay will be available
through April 21, 2007 by dialing (719) 457-0820 or (888) 203-1112
(international) and using the conference confirmation code 1892814.
A live audio webcast of the call will also be available on the
"Investor Relations" section of the company's website,
http://www.achillion.com. An archived audio webcast will be available on
the Achillion website approximately two hours after the event and will be
archived for three months.
About Achillion
Achillion is a biopharmaceutical company focused on the discovery,
development and commercialization of innovative treatments for infectious
diseases. Achillion is currently developing treatments for HIV infection,
chronic hepatitis C infection and serious hospital-based bacterial
infections. For more information on Achillion Pharmaceuticals, please visit
the company's web site at http://www.achillion.com or call Achillion at
1-203-624-7000. ACHN-G
Contact: Media:
Mary Kay Fenton Kari Watson
Achillion Pharmaceuticals, Inc. MacDougall Biomedical Communications
Tel. (203) 624-7000 Tel. (508) 647-0209
mfenton@achillion.com kwatson@macbiocom.com
SOURCE Achillion Pharmaceuticals, Inc.
 back to top
Related links:
http://www.macbiocom.com
http://www.achillion.com http://www.achillion.com
CONTACT:
Mary Kay Fenton of Achillion Pharmaceuticals,
Inc., +1-201-624-7000, mfenton@achillion.com; or Kari Watson of
MacDougall Biomedical Communications, +1-508-647-0209,
kwatson@macbiocom.com for Achillion Pharmaceuticals, Inc.
|
